Skip to main content

Table 3 Pooled effect of HBV/HCV coinfection studies with HCV mono-infection control studies

From: The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis

Effects HBV/HCV HCV Effect size Heterogeneity
  Studies (n) Sample size Events Sample size Events OR(95% CI) P I 2 P
ETVR 4 271 233 308 266 1.03(0.37-2.82) 0.96 69% 0.02
SVR 5 313 213 392 276 0.87(0.62-1.21) 0.38 0% 0.61
HCV relapse 4 270 49 308 42 1.55(0.98-2.47) 0.06 47% 0.13
HCV genotype 1 relapse 2 127 27 135 13 2.4(1.17-4.91) 0.19 74% 0.05
HCV non-genotype 1 relapse 2 84 7 71 7 0.9(0.3-2.71) 0.85 0% 0.4o
  1. OR odds ratio.